Behavioural sensitization in 6-hydroxydopamine-lesioned rats is related to compositional changes of the AP-1 transcription factor: Evidence for induction of FosB- and JunD-related proteins

Molecular Brain Research

Volumn 52, Issue 2, 1997, Pages 307-317

  Vallone, Daniela ^c   Pellecchia, Maria Teresa ^a   Morelli, Micaela ^b   Verde, Pasquale ^c   DiChiara, Gaetano ^b   Barone, Paolo ^a,d  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

^c INSTITUTE OF GENETICS AND BIOPHYSICS ADRIANO BUZZATI TRAVERSO   (Italy)

^d IRCCS NEUROMED   (Italy)

Author keywords

6 Hydroxydopamine; AP 1; cFos; Dopamine agonist; FosB; JunD; Priming; Supersensitivity

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; DIZOCILPINE; DOPAMINE RECEPTOR STIMULATING AGENT; GLUTAMATE RECEPTOR ANTAGONIST; ONCOPROTEIN; OXIDOPAMINE; TRANSCRIPTION FACTOR AP 1;

ANIMAL TISSUE; ARTICLE; BEHAVIOR; BRAIN INJURY; CONTROLLED STUDY; DENERVATION; MALE; NONHUMAN; ONCOGENE C FOS; ONCOGENE C JUN; PRIORITY JOURNAL; PROTEIN INDUCTION; RAT; SENSITIZATION;

2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINE; ANIMALS; BENSERAZIDE; CELL NUCLEUS; CORPUS STRIATUM; DENERVATION; DIZOCILPINE MALEATE; GENE EXPRESSION REGULATION; LEVODOPA; MALE; MOTOR ACTIVITY; NEURONS; OXIDOPAMINE; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN; RATS; RATS, SPRAGUE-DAWLEY; ROTATION; STEREOTYPED BEHAVIOR; TRANSCRIPTION FACTOR AP-1;

ANIMALIA;

EID: 0031574371     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(97)00253-2     Document Type: Article

References (42)

1. [1] P. Angel, M. Karin, The role of Jun, Fos and AP-1 complex in cell prolification and transformation, Biochem. Biophys. Acta 1072 (1991) 129-157.
2. [2] P. Barone, M. Morelli, M. Popoli, G. Cicarelli, G. Campanella, G. Di Chiara, Behavioural sensitization in 6-hydroxydopamine lesioned rats involves the dopamine signal transduction: changes in DARPP-32 phosphorylation, Neuroscience 61 (1994) 867-873.
3. [3] G. Bing, W. Wang, Q. Qi, Z. Feng, P. Hudson, L. Jin, W. Zhang, R. Bing, J.S. Hong, Long-term expression of Fos-related antigen and transient expression of ΔFosB associated with seizures in the rat hippocampus and striatum, J. Neurochem. 68 (1997) 272-279.
4. [4] P.K. Brindle, M.R. Montminy, The CREB family of transcription activators, Curr. Opin. Genet. Dev. 2 (1992) 199-204.
5. [5] D.M. Bronstein, H. Ye, K.R. Pennypacker, P.M. Hudson, J.S. Hong, Role of a 35 kDa fos-related antigen (FRA) in the long-term induction of striatal dynorphin expression in the 6-hydroxydopamine lesioned rat, Mol. Brain Res. 23 (1994) 191-203.
6. [6] J. Chen, H.E. Nye, M.B. Kelz, N. Hiroi, B.T. Nakabeppu, J. Nestler, Regulation of ΔFosB ad FosB-like proteins by electroconvulsive seizure and cocaine treatments, Mol. Pharmacol. 48 (1995) 880-889.
7. [7] P. Chomczynski, N. Sacchi, Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction, Anal. Biochem. 162 (1987) 156-159.
8. [8] D.G. Cole, L.A. Kobierski, K. Konradi, S.E. Hyman, 6-Hydroxydopamine lesions of rat substantia nigra up-regulate dopamine-induced phosphorylation of the cAMP-response element-binding protein in striatal neurons, Proc. Natl. Acad. Sci. USA 91 (1994) 9631-9635.
9. [9] M.J. Comb, L. Kobierski, H.M. Chu, Y. Tan, D. Borsook, K. Herrup, S.E. Hyman, Regulation of opioid gene expression: a model to understand neural plasticity, NIDA Res. Monogr. 126 (1992) 98-112.
10. [10] G. Di Chiara, M. Morelli, P. Barone, F. Pontieri, Priming as a model of behavioural sensitization, Dev. Pharmacol. Ther. 18 (1992) 223-227.
11. [11] P. Dobrzanski, T. Noguchi, K. Kovary, C.A. Rizzo, P.S. Lazo, R. Bravo, Both products of the fosB gene, FosB and its short form, FosB/SF, are transcriptional activators in fibroblasts, Mol. Cell Biol. 11 (1991) 5470-5478.
12. [12] J.P. Doucet, Y. Nakabeppu, P.J. Bedard, B.T. Hope, E.J. Nestler, B.J. Jasmin, J.S. Chen, M.J. Iadarola, M. St-Jean, N. Wigle, P. Blanchet, R. Grondin, G.S. Robertson, Chronic alterations in dopaminergic neurotransmission produce a persistent elevation of ΔFosB-like protein(s) in both the rodent and primate striatum, Eur. J. Neurosci. 8 (1996) 365-381.
13. [13] M. Dragunow, J.D. Leah, R.L. Faull, Prolonged and selective induction of Fos-related antigens in striatal neurons after 6-hydroxydopamine lesions of the rat substantia nigra pars compacta, Mol. Brain Res. 10 (1991) 355-358.
14. [14] M. Dragunow, N. Butterworth, H. Waldvogel, R.L. Faull, L.F. Nicholson, Prolonged expression of Fos-related antigens, JunB and TrkB in dopamine-denervated striatal neurons, Mol. Brain Res. 30 (1995) 393-396.
15. [15] J. Fornaguera, R.J. Carey, J.P. Huston, R.K.W. Schwarting, Behavioral asymmetries and recovery in rats with different degrees of unilateral striatal dopamine depletion, Brain Res. 664 (1994) 178-188.
16. [16] S.I. Hirai, F. Mechta, R. Bravo, M. Yaniv, Characterization of JunD: a new member of Jun proto-oncogene family, EMBO J. 8 (1989) 1433-1439.
17. [17] B.T. Hope, M.B. Kelz, R.S. Duman, E.J. Nestler, Chronic electroconvulsive seizure (ECS) treatment results in expression of a long-lasting AP-1 complex in brain with altered composition and characteristics, J. Neurosci. 14 (1994) 4318-4328.
18. [18] B.T. Hope, H.E. Nye, M.B. Kelz, D.W. Self, M.J. Iadarola, Y. Nakabeppu, R.S. Duman, E.J. Nestler, Induction of a long-lasting AP-1 complex composed of altered Fos-like proteins in brain by chronic cocaine and other chronic treatments, Neuron 13 (1994) 1235-1244.
19. [19] B. Kaminska, R.K. Filipkowski, G. Zurkowska, W. Lason, R. Przewlocki, L. Kaczmarek, Dynamic changes in the composition of the AP-1 transcription factor DNA-binding activity in rat brain following kainate-induced seizures and cell death, Eur. J. Neurosci. 6 (1994) 1558-1566.
20. [20] T.K. Kerppola, T. Curran, Fos-Jun heterodimers and Jun homodimers bend DNA in apposite orientation: implications for transcription factor cooperativity, Cell 66 (1991) 317-326.
21. [21] P.S. Lazo, K. Dorfman, T. Noguchi, M.G. Mattéi, R. Bravo, Structure and mapping of the fosB gene. FosB downregulates the activity of the fosB promoter, Nucleic Acids Res. 20 (1992) 343-350.
22. [22] H. Matsuda, Y. Akechi, Y. Shimada, K. Terasawa, H. Watanabe, Relationship of the ipsilateral rotation in night period and striatal dopamine content reduction in unilateral nigrostriatal 6-OHDA lesioned rats, Brain Res. 686 (1995) 111-114.
23. [23] M. Morelli, G. Di Chiara, Agonist-induced homologous and heterologous sensitization to D1 and D2 dependent contraversive turning, Eur. J. Pharmacol. 141 (1987) 101-107.
24. [24] M. Morelli, G. De Montis, G. Di Chiara, Changes in the D1 receptor-adenylate cyclase complex after priming, Eur. J. Pharmacol. 180 (1990) 365-367.
25. [25] M. Morelli, S. Fenu, A. Carta, G. Di Chiara, Effect of MK 801 on priming of D1-dependent contralateral turning and its relationship to c-fos expression in the rat caudate-putamen, Behav. Brain Res. 79 (1996) 93-100.
26. [26] J.I. Morgan, T. Curran, Stimulus-transcription coupling in neurons: role of cellular immediate-early genes, Trends Neurol. Sci. 12 (1989) 459-462.
27. [27] Y. Nakabeppu, D. Nathans, A naturally occurring truncated form of fosB that inhibits Fos/Jun transcriptional activity, Cell 64 (1991) 751-759.
28. [28] J.R. Naranjo, B. Mellstrom, M. Achaval, P. Sassone-Corsi, Molecular pathways of pain: Fos/Jun-mediated activation of a noncanonical AP-1 site in the prodynorphin gene, Neuron 6 (1991) 607-617.
29. [29] E.J. Nestler, B.T. Hope, K. Widnell, Drug addiction: a model for the molecular basis of neural plasticity, Neuron 11 (1993) 995-1006.
30. [30] A.G. Papavassiliou, Transcription factors, Mol. Med. 332 (1995) 45-47.
31. [31] M.L. Paul, A.M. Graybiel, J.C. David, H.A. Robertson, D1-like and D2-like dopamine receptors synergistically activate rotation and c-fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease, J. Neurosci. 12 (1992) 3729-3742.
32. [32] M.L. Paul, R.W. Currie, H.A. Robertson, Priming of a D1 dopamine receptor behavioural response is dissociated from striatal immediate-early gene activity, Neuroscience 66 (1995) 347-359.
33. [33] L.J. Pellegrino, A.S. Pellegrino, A. Cushman, A Stereotaxic Atlas of The Rat Brain, Plenum, New York, NY, 1979.
34. [34] K. Pennypacker, L. Thai, J.S. Hong, M.K. McMillian, Prolonged expression of AP-I transcription factors in the rat hippocampus after systemic kainate treatment, J. Neurosci. 14 (1994) 3998-4006.
35. [35] K.R. Pennypacker, J.S. Hong, M.K. McMillian, Implications of prolonged expression of Fos-related antigens, Trends Pharmacol. Sci. 16 (1995) 317-321.
36. [36] H.A. Robertson, M.R. Peterson, K. Murphy, G.S. Robertson, D1-dopamine receptor agonists selectively activate striatal c-Fos independent of rotational behaviour, Brain Res. 503 (1989) 346-349.
37. [37] J. Sambrook, E.F. Fritsch, T. Maniatis, Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, 1989.
38. [38] C.S. Simpson, B.J. Morris, Induction of c-fos and zif/268 gene expression in rat striatal neurons, following stimulation of D1-like dopamine receptors, involves protein kinase A and protein kinase C, Neuroscience 68 (1995) 97-106.
39. [39] U. Ungerstetd, Postsynaptic supersensitivity after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system, Acta Physiol. Scand. 367 (1971) 69-93.
40. [40] H. Van Dam, M. Duyndam, R. Rottier, A. Bosch, L. De Vries-Smits, P. Herrlich, A. Zantema, P. Angel, A.J. Van der Eb, Heterodimer formation of c-Jun and ATF-2 is responsible for induction of c-jun by the 243 amino acid adenovirus E1A protein, EMBO J. 12 (1993) 479-481.
41. [41] T. Yamada, S. Nakao, S. Osada, M. Imagawa, T. Nishihara, Sequence analysis of the rat jun-D gene, Gene 153 (1995) 285-286.
42. [42] M. Zerial, L. Toschi, R.P. Ryseck, M. Schuermann, W. Muller, R. Bravo, The product of a novel growth factor activated gene, fosB, interacts with Jun proteins enhancing their binding activity, EMBO J. 8 (1989) 805-813.